Albuterol Spiromax

DRUG3 trials

Sponsors

Teva Branded Pharmaceutical Products R&D, Inc.

Conditions

AsthmaExercise-Induced Bronchoconstriction (EIB)

Phase 2

Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients

CompletedNCT01899144

Teva Branded Pharmaceutical Products R&D, Inc.Asthma

Start: 2013-07-31End: 2013-10-31Updated: 2022-01-26

Phase 3

A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing

TerminatedNCT01218009

Teva Branded Pharmaceutical Products R&D, Inc.Asthma

Start: 2010-10-31End: 2010-12-31Updated: 2015-05-20

Efficacy of Albuterol SPIROMAX® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB)

CompletedNCT01791972

Teva Branded Pharmaceutical Products R&D, Inc.Exercise-Induced Bronchoconstriction (EIB)

Start: 2013-03-31End: 2013-06-30Updated: 2015-06-18

Related Papers

Albuterol multidose dry powder inhaler and albuterol hydrofluoroalkane versus placebo in children with persistent asthma

Allergy and Asthma Proceedings2016-08-191 citations

Pharmacokinetics and pharmacodynamics of albuterol multidose dry powder inhaler and albuterol hydrofluoroalkane in children with asthma

Allergy and Asthma Proceedings2016-08-151 citations

Novel albuterol multidose dry powder inhaler in patients with exercise-induced bronchoconstriction: A single-dose, double-blind, randomized, 2-way crossover study.

2015-09-084 citations